Inhibrx Biosciences (INBX) Other Gross PP&E Adjustments (2023 - 2025)
Inhibrx Biosciences (INBX) has disclosed Other Gross PP&E Adjustments for 3 consecutive years, with $8.9 million as the latest value for Q3 2025.
- On a quarterly basis, Other Gross PP&E Adjustments fell 34.58% to $8.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.9 million, a 34.58% decrease, with the full-year FY2024 number at $7.8 million, down 23.63% from a year prior.
- Other Gross PP&E Adjustments was $8.9 million for Q3 2025 at Inhibrx Biosciences, up from $8.7 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $13.6 million in Q3 2024 to a low of $7.8 million in Q4 2024.
- A 3-year average of $10.0 million and a median of $8.9 million in 2025 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: dropped 23.63% in 2024, then tumbled 34.58% in 2025.
- Inhibrx Biosciences' Other Gross PP&E Adjustments stood at $10.2 million in 2023, then fell by 23.63% to $7.8 million in 2024, then rose by 14.47% to $8.9 million in 2025.
- Per Business Quant, the three most recent readings for INBX's Other Gross PP&E Adjustments are $8.9 million (Q3 2025), $8.7 million (Q2 2025), and $8.2 million (Q1 2025).